Home Circulars 2013 SEBI SEBI - 2013 This
Forgot password New User/ Regiser ⇒ Register to get Live Demo
Establishment of Connectivity with both depositories NSDL and CDSL – Companies eligible for shifting from Trade for Trade Settlement (TFTS) to Normal Rolling Settlement - SEBI - CIR/MRD/DP/19/2013Extract CIRCULAR CIR/MRD/DP/19/2013 June 11, 2013 To, All Stock Exchanges Dear Sir / Madam, Sub: Establishment of Connectivity with both depositories NSDL and CDSL Companies eligible for shifting from Trade for Trade Settlement (TFTS) to Normal Rolling Settlement 1. It is observed from the information provided by the depositories that the companies listed in Annexure A have established connectivity with both the depositories. 2. The stock exchanges may consider shifting the trading in these securities to normal Rolling Settlement subject to the following: a) At least 50% of other than promoter holdings as per clause 35 of Listing Agreement are in dematerialized mode before shifting the trading in the securities of the company from TFTS to normal Rolling Settlement. For this purpose, the listed companies shall obtain a certificate from its Registrar and Transfer Agent (RTA) and submit the same to the stock exchange/s. However, if an issuer-company does not have a separate RTA, it may obtain a certificate in this regard from a practicing company Secretary/Chartered Accountant and submit the same to the stock exchange/s. b) There are no other grounds/reasons for continuation of the trading in TFTS. 3. The Stock Exchanges are advised to report to SEBI, the action taken in this regard in the Monthly/Quarterly Development Report. Yours faithfully, Maninder Cheema Deputy General Manager email: [email protected] Annexure A Sr. No. Name of the Company ISIN 1. Jauss Polymers Limited INE593O01017 2. Malti Textiles Mills Limited INE907N01011 3. Techtrek India Limited INE892N01015 4. Combat Drugs Limited INE643N01012 5. Mehta Housing Finance Limited INE239B01014 6. Essen Supplements India Limited INE716K01012 7. Adi Rasayan Limited INE861N01010 8. Shree Ganesh Biotech (India) Ltd INE051N01018
|